Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Ex-Sandoz exec admits role in generic drug price-fixing plot

Reignites criticism of high drug prices in the US

- PMLiVE

Merck’s Ebola vaccine wins approval in four African countries

Follows approvals in US and Europe last year

- PMLiVE

Porter Novelli adds Amber Tovey to London health team

Tovey joins the team as business director

- PMLiVE

ReNeuron set for recovery after Woodford stake sale

Edison analyst says sale should help shares to stabilise

- PMLiVE

Servier and Oncodesign reach first milestone in Parkinson’s partnership

Oncodesign receives first success payment of €1m

Novartis day

Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD

New drug due for launch in Europe in the second quarter

- PMLiVE

Weirdos and misfits

Can diversity improve engagement in healthcare?

- PMLiVE

SMC enables access to Kyowa Kirin’s Crysvita for rare bone disease

Drug is being reviewed under new ultra-orphan pathway

- PMLiVE

BMS unveils long-term results for Opdivo in kidney cancer

Results include updated data for Opdivo with or without Yervoy

- PMLiVE

Roche’s PD-L1 inhibitor Tecentriq approved in China for SCLC

Solidifies immunotherapy drug's dominance in the setting

- PMLiVE

After FDA refusal, Takeda builds case for subcutaneous Entyvio

Intravenous Entyvio is already available in 60 countries

New strategic blueprint: the new first questions

By Thunicia Moodley

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links